105 related articles for article (PubMed ID: 2780779)
1. Dissociation of naloxone-sensitive and naloxone-insensitive effects of U-50,488H.
Young GA
Pharmacol Biochem Behav; 1989 May; 33(1):215-7. PubMed ID: 2780779
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol pretreatment unmasks the kappa opioid effects of U-50, 488H on cortical EEG and EEG power spectra in rats.
Young GA; Marquis KL; Paquette NC; Gussio RP; Khazan N
Neuropharmacology; 1989 Aug; 28(8):881-4. PubMed ID: 2550842
[TBL] [Abstract][Full Text] [Related]
3. Interactions between U-50,488H and sigma receptor antagonists: EEG, EEG power spectral and behavioral correlates.
Young GA; Hudson GM; Stamidis H; Steinfels GF
Eur J Pharmacol; 1993 Feb; 231(3):473-6. PubMed ID: 8095467
[TBL] [Abstract][Full Text] [Related]
4. The effect of kappa-opioid agonist U-50, 488H on wet-dog shaking behavior induced by hippocampal stimulation in rats.
Ohno M; Yamamoto T; Araki H; Ueki S
Psychopharmacology (Berl); 1987; 91(2):189-92. PubMed ID: 3107029
[TBL] [Abstract][Full Text] [Related]
5. The interaction between kappa-opioid agonist, U-50, 488H, and kainic acid: behavioral and histological assessments.
Lason W; Simpson JN; McGinty JF
Brain Res; 1989 Mar; 482(2):333-9. PubMed ID: 2539886
[TBL] [Abstract][Full Text] [Related]
6. Differential tolerance to repeated daily injections of N-allylnormetazocine and its enantiomers in the rat.
Young GA; Hong O; Khazan N
Neuropharmacology; 1987 May; 26(5):463-7. PubMed ID: 3037416
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion.
Pugsley MK; Penz WP; Walker MJ; Wong TM
Eur J Pharmacol; 1992 Feb; 212(1):15-9. PubMed ID: 1555635
[TBL] [Abstract][Full Text] [Related]
8. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
Alcaraz C; Milanés MV; Vargas ML
J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
Pugsley MK; Penz WP; Walker MJ; Wong TM
Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
[TBL] [Abstract][Full Text] [Related]
10. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
11. The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity.
Leyton M; Stewart J
Brain Res; 1992 Oct; 594(1):56-74. PubMed ID: 1334765
[TBL] [Abstract][Full Text] [Related]
12. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
[TBL] [Abstract][Full Text] [Related]
13. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
Kamei J; Tanihara H; Kasuya Y
Eur J Pharmacol; 1990 Oct; 187(2):281-6. PubMed ID: 2272363
[TBL] [Abstract][Full Text] [Related]
14. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
Bileviciute-Ljungar I; Spetea M
Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
[TBL] [Abstract][Full Text] [Related]
15. Consequences of opiate agonist and antagonist in myocardial ischaemia suggest a role of endogenous opioid peptides in ischaemic heart disease.
Lee AY; Chen YT; Kan MN; P'eng FK; Chai CY; Kuo JS
Cardiovasc Res; 1992 Apr; 26(4):392-5. PubMed ID: 1638574
[TBL] [Abstract][Full Text] [Related]
16. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1990 Jul; 254(1):8-12. PubMed ID: 2164102
[TBL] [Abstract][Full Text] [Related]
17. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
Morrone LA; Romanelli L; Amico MC; Valeri P
Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
[TBL] [Abstract][Full Text] [Related]
18. Electroencephalographic and behavioral effects of D-ala2-methionine-enkephalinamide and morphine in the rat.
Tortella FC; Moreton JE; Khazan N
J Pharmacol Exp Ther; 1978 Sep; 206(3):636-43. PubMed ID: 702326
[TBL] [Abstract][Full Text] [Related]
19. Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys.
Heath RG; Fitzjarrell AT; Walker CF
Biol Psychiatry; 1984 Jul; 19(7):1045-74. PubMed ID: 6089918
[TBL] [Abstract][Full Text] [Related]
20. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
